Susmed

Susmed Interest Coverage

The Interest Coverage Ratio of Susmed (4263.T) as of Oct 29, 2026 is -898.97. In the previous year, Interest Coverage Ratio was -24,769.50 — a change of -96.37% (higher).

Interest Coverage

-898.97

YoY

-96.37%

Last updated:

Interest Coverage Ratio of Susmed is 2024 -898.97 . Interest Coverage Ratio of Susmed was 2023 -24,769.50 . It decreases by -96.37% higher compared to the previous year.

The Susmed Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2020
-40,182.00 JPY
Jan 1, 2021
-55,570.17 JPY
Jan 1, 2022
-116,581.50 JPY
Jan 1, 2023
-24,769.50 JPY
Jan 1, 2024
-898.97 JPY
The Susmed Interest Coverage history
YEARInterest CoverageYoY
-898.97-96.37%
-24,769.50-78.75%
-116,581.50+109.79%
-55,570.17+38.30%
-40,182.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Susmed Stock analysis

What does Susmed do? SUSMED, Inc. generates revenue through its DTx Product segment, which develops application software for treating insomnia, breast cancer, and chronic kidney diseases. The DTx Platform segment provides clinical trial systems, machine learning analysis systems, and DTx development support services. The company's primary customers are healthcare providers and pharmaceutical companies seeking digital therapeutics solutions. SUSMED targets the healthcare technology market with its specialized software and support services for disease treatment and clinical research. The DTx Product segment focuses on creating therapeutic applications for specific medical conditions, while the DTx Platform segment offers infrastructure for clinical trials and machine learning analysis. SUSMED's business model relies on selling both its proprietary software products and platform services to healthcare institutions and pharmaceutical firms. The company's revenue streams include software licensing, system subscriptions, and development support fees. SUSMED's products are designed to address chronic conditions like insomnia and breast cancer, with additional focus on chronic kidney diseases. The DTx Platform serves as a comprehensive solution for clinical trial management and machine learning-driven analysis, supporting pharmaceutical companies in their drug development processes. The company's services are tailored to meet the needs of healthcare technology providers and pharmaceutical developers. Susmed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Susmed stock

Interest Coverage Ratio of Susmed is -898.97 in 2024.

Interest Coverage Ratio of Susmed changed from -24,769.50 to -898.97, representing a -96.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Susmed since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Susmed with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Susmed

All Key Metrics — Susmed